WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study.
about
Children's Oncology Group's 2013 blueprint for research: renal tumorsMolecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan AfricaInnovations in the management of Wilms' tumor.Biomarkers for Wilms Tumor: A Systematic ReviewClinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours.Wilms tumor.Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic reviewMultidetector CT imaging features of invasive renal parenchyma urothelial carcinoma.Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.Profiling Loss of Heterozygosity Patterns in a Cohort of Favorable Histology Nephroblastoma Egyptian Patients: What is Consistent With the Rest of the World.The IGF signalling pathway in Wilms tumours--a report from the ENCCA Renal Tumours Biology-driven drug development workshop.Association between long interspersed nuclear element-1 methylation levels and relapse in Wilms tumors.CT and MRI imaging features and long-term follow-up of adult Wilms' tumor.Imaging features of primary renal lymphoma.
P2860
Q27000449-4914660C-00E5-43EC-BC56-6D993922D3CDQ30449310-FFD4433C-6B53-44C3-979B-C28EC4688ED5Q33744269-6E547F6C-D626-4D14-855C-1F20D71CF966Q36040458-F29D2611-E894-4A13-AF39-623016543503Q36200428-0041D864-9644-4C49-9D43-B433B5CEB8F8Q36392072-E5EAABE7-093B-4B7A-8266-B5FDB4606B3DQ36661062-AD24A090-C418-445D-A624-18880F75E9E3Q37146691-19CB66E3-1868-4594-A3D7-E4200423FA33Q37600902-C21ABD94-44CE-4785-B939-A65CAC41DA20Q38998052-2442C139-3C66-489D-A893-F878D2FB961AQ39000999-06137763-6E75-4B1B-816E-03328FEAB437Q42995400-87A8FD46-0BD6-422F-9F9E-604F1AF84A8AQ47104294-76C5C535-D536-4814-9855-1BFE4616E608Q52664397-324B946A-80EC-4633-BB4A-A8776A986597Q52943634-15F8365E-0F5F-424D-B0E5-975B9D61FA11
P2860
WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
WT1 mutation and 11P15 loss of ...... ildren's oncology group study.
@ast
WT1 mutation and 11P15 loss of ...... ildren's oncology group study.
@en
WT1 mutation and 11P15 loss of ...... ildren's oncology group study.
@nl
type
label
WT1 mutation and 11P15 loss of ...... ildren's oncology group study.
@ast
WT1 mutation and 11P15 loss of ...... ildren's oncology group study.
@en
WT1 mutation and 11P15 loss of ...... ildren's oncology group study.
@nl
prefLabel
WT1 mutation and 11P15 loss of ...... ildren's oncology group study.
@ast
WT1 mutation and 11P15 loss of ...... ildren's oncology group study.
@en
WT1 mutation and 11P15 loss of ...... ildren's oncology group study.
@nl
P2093
P2860
P356
P1476
WT1 mutation and 11P15 loss of ...... ildren's oncology group study.
@en
P2093
Daniel M Green
E Cristy Ruteshouser
Elizabeth J Perlman
James R Anderson
Jeffrey S Dome
Lawrence J Jennings
Paul E Grundy
Robert C Shamberger
Vicki Huff
P2860
P304
P356
10.1200/JCO.2010.31.5192
P407
P577
2010-12-28T00:00:00Z